Although alterations in the p53 or Rb pathway are common in osteosarcoma, Franceschini et al. demonstrated that the loss of both p53 and p16Ink4a is crucial for transforming mesenchymal stem cells (MSCs) into osteosarcoma cells [46]. Here, CDKN2A is linked to osteosarcoma.